Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis

Epidemiology

Volumn 23, Issue 6, 2012, Pages 852-860

  De Greeff, Sabine C ^a   De Melker, Hester E ^a   Westerhof, Anneke ^a   Schellekens, Joop F P ^b   Mooi, Frits R ^a   Van Boven, Michiel ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Laboratory for Infectious Diseases   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COCOONING VACCINATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FATHER; HOUSEHOLD; HUMAN; INFANT; INFANT DISEASE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MOTHER; NETHERLANDS; PERTUSSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIBLING; STOCHASTIC MODEL; VACCINATION;

ADULT; CHILD; FAMILY CHARACTERISTICS; FAMILY HEALTH; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MODELS, STATISTICAL; NETHERLANDS; PERTUSSIS VACCINE; STOCHASTIC PROCESSES; VACCINATION; WHOOPING COUGH;

EID: 84867575488     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31826c2b9e     Document Type: Article

References (33)

1. Roush S W, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155-2163.
2. Celentano L P, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24:761-765.
3. Güri D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28:1230-1237.
4. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Commun Dis Intell. 2007;31:205-215.
5. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis. 2000;182:1409-1416.
6. Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS. 2009;117:912-922.
7. de Greeff SC, de Melker HE, van Gageldonk PG, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Borde-tella pertussis. PLoS ONE. 2010;5:e14183.
8. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010;10:36-49.
9. Berbers GA, de Greeff SC, Mooi FR. Improving pertussis vaccination. Hum Vaccin. 2009;5:497-503.
10. de Greeff SC, Mooi FR, Westerhof A, et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50: 1339-1345.
11. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J. 2004;23:246-252.
12. O'Brien JA, Caro JJ. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis. 2005;5:57.
13. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 suppl):S58-S61.
14. Ball F, O'Neill PD. The distribution of general final state random variables for stochastic epidemic models. J Appl Probab. 1999;36:473-491.
15. Smith MJ, Telfer S, Kallio ER, et al. Host-pathogen time series data in wildlife support a transmission function between density and frequency dependence. Proc Natl Acad Sci U S A. 2009;106:7905-7909.
16. van Boven M, Donker T, van der Lubben M, et al. Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS ONE. 2010;5:e11442.
17. Addy CL, Longini IM Jr, Haber M. A generalized stochastic model for the analysis of infectious disease final size data. Biometrics. 1991;47:961-974.
18. van Boven M, Koopmans M, Du Ry van Beest Holle M, et al. Detecting emerging transmissibility of avian influenza virus in human households. PLoS Comput Biol. 2007;3:e145.
19. Diekmann O, Heesterbeek JAP. Mathematical epidemiology of infectious diseases. Model Building, Analysis and Interpretation. New York: Wiley; 2000.
20. Burnham K P, Anderson DR. Model selection and Multimodel Ineference. New York: Springer; 2002.
21. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23:985-989.
22. Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol. 2007;4:15.
23. Crowcroft NS, Booy R, Harrison T, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child. 2003;88:802-806.
24. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis. 1990;161:480-486.
25. Nooitgedagt JE, de Greeff SC, Elvers BH, et al. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin. Clin Infect Dis. 2009;49:1086-1089.
26. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614-624.
27. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52:157-162.
28. Van Rie A, Hethcote H W. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine. 2004;22:3154-3165.
29. Forsyth K, Tan T, von König CH, Caro JJ, Plotkin S. Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J. 2005;24(5 suppl):S69-S74.
30. Coudeville L, Van Rie A, Getsios D, Caro JJ, Crépey P, Nguyen VH. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS ONE. 2009;4:e6284.
31. Coudeville L, van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect. 2008;136: 604-620.
32. Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Pediatr Infect Dis J. 2007;26:806-810.
33. Guiso N, Wirsing von König CH, Forsyth K, Tan T, Plotkin SA. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine. 2011;29:1115-1121.